Monte Rosa Therapeutics Inc (GLUE)
Stock-Based Compensation
$5.97M
Quarterly · Period ending: · USD
GLUE Stock-Based Compensation
Latest reported$5.97Mperiod ending
Latest reported$5.97Mperiod ending
GLUE Quarterly Stock-Based Comp ($11.00K → $5.97M)
Quarterly stock-based compensation
High-resolution chart · PNG
GLUE stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,970,000 | |
| 5,949,000 | |
| 4,309,000 | |
| 4,364,000 | |
| 4,894,000 | |
| 5,298,000 | |
| 4,469,000 | |
| 4,282,000 | |
| 4,502,000 | |
| 4,873,000 | |
| 4,074,000 | |
| 4,468,000 | |
| 4,153,000 | |
| 3,974,000 | |
| 3,326,000 | |
| 3,214,000 | |
| 2,873,000 | |
| 2,251,000 | |
| 1,856,000 | |
| 2,073,000 | |
| 1,019,000 | |
| 252,000 | |
| 201,000 | |
| 45,000 | |
| 97,000 | |
| 11,000 |